FDA
-
-
-
-
-
-
-
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
-
-
-
-
-
-
-
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
-
-
-
-
-
-
-
GT Biopharma Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
GT Biopharma Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
GT Biopharma Affirms Manufacturing Timeline For Lead Investigational Asset GTB-3650
-
-
-
-
-
-
-
GT BioPharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
GT Biopharma to Present at Upcoming September Investor Conferences
-
334,842 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


